Physician profile
Lawrence B Colen
NPI 1255442174
$9,122.52
in general payments reported to CMS, 2019-2025
29 companies · $1,677 in 2025
The $1,677 reported for 2025 was more than what 81% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $1,898 · 2021: $793 · 2022: $1,252 · 2023: $1,214 · 2024: $1,886 · 2025: $1,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,367 · Long Term Medical Supply Or Device Loan: $326 · Travel and Lodging: $59.75 · Entertainment: $24.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,367.32 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Travel and Lodging | $59.75 |
| Entertainment | $24.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $3,404.81 | 2019-2024 | |
| Integra Lifesciences Corporation | $995.24 | 2021-2025 | Integra, Durasorb Monofilament Mesh, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $708.19 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Lifenet Health | $511.00 | 2024-2025 | Theragenesis Wound Matrix |
| Davol INC. | $485.78 | 2022-2023 | Phasix Mesh |
| Sanara Medtech INC. | $414.28 | 2023-2025 | Celleraterx, Celleraterx |
| Kerecis Limited | $391.25 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Polynovo North America LLC | $307.61 | 2022-2025 | Novosorb Btm |
| Sientra, INC. | $260.47 | 2021-2022 | |
| Innovation Technologies INC | $260.39 | 2023-2025 | Irrisept |
| Allergan, INC. | $259.27 | 2019-2022 | |
| Mimedx Group, INC. | $198.41 | 2024-2025 | |
| Smith+Nephew, INC. | $165.38 | 2021-2024 | Stravix, Grafix, Oasis |
| Rti Surgical, INC | $126.66 | 2022 | |
| Coopersurgical, INC. | $95.47 | 2025 | Onetrac Lx |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $85.37 | 2024-2025 | |
| Motiva USA, LLC | $58.85 | 2025 | |
| Sonex Health, INC. | $54.19 | 2024 | Sx-One Microknife |
| Organogenesis INC. | $46.56 | 2025 | Puraply Wound Matrix |
| Misonix INC | $44.44 | 2020-2021 | |
| Bioventus LLC | $40.07 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Galderma Laboratories, L.P. | $33.93 | 2022-2023 | |
| Avita Medical Americas, LLC | $30.14 | 2023 | Recell |
| Checkpoint Surgical, INC | $28.62 | 2022 | |
| Acell, INC. | $26.99 | 2019 | |
| Kci USA, INC. | $26.56 | 2023 | Prevena |
| Merz North America, INC. | $26.30 | 2021 | |
| Hydrofera LLC | $18.34 | 2022 | |
| Convatec INC. | $17.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Colen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.